首页> 美国卫生研究院文献>AAPS PharmSciTech >Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose
【2h】

Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose

机译:壳聚糖类型对微晶纤维素含量低的挤出粒料性能的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this research was to study the influence of type of chitosan with different molecular weights, ie, 190 and 419 kDa, on properties of pellets prepared by extrusion/ spheronization. The formulations, consisting of acetaminophen as model drug, chitosan, microcrystalline cellulose (MCC), and dibasic calcium phosphate dihydrate with/without sodium alginate, were extruded using a twin-screw extruder and water as the granulating liquid. With 30% wt/wt MCC and no added sodium alginate, spherical pellets were produced containing low and high molecular weight chitosan at a maximum amount of 60% and 40% wt/wt, respectively. With sodium alginate (2.5% wt/wt), pellets with either type of chitosan (60% wt/wt), MCC (17.5% wt/wt), and acetaminophen (20% wt/wt) could be produced indicating an improved pelletforming ability. Type and amount of chitosan and added sodium alginate affected physical properties of pellets including size, roundness, crushing force, and drug release. Low molecular weight chitosan produced pellets with higher mean diameter, sphericity, and crushing force. Additionally, the pellets made of low molecular weight chitosan and added sodium alginate showed faster drug release in 0.1 N HCl but had slower drug release in pH 7.4 phosphate buffer. This indicated that drug release from pellets could be modified by the molecular weight of chitosan. In conclusion, the molecular weight of chitosan had a major influence on formation, physical properties, and drug release from the obtained pellets.
机译:这项研究的目的是研究不同分子量(即190和419 kDa)的壳聚糖类型对通过挤出/滚圆法制备的颗粒性能的影响。使用双螺杆挤出机和以水为制粒液挤出由对乙酰氨基酚作为模型药物,壳聚糖,微晶纤维素(MCC)和含或不含海藻酸钠的磷酸氢钙二水合物组成的制剂。用30%wt / wt的MCC并且不添加海藻酸钠,制得的球形粒料包含低和高分子量壳聚糖,最大含量分别为60%和40%wt / wt。使用藻酸钠(2.5%wt / wt),可以生产具有壳聚糖(60%wt / wt),MCC(17.5%wt / wt)和对乙酰氨基酚(20%wt / wt)中的任一种的丸粒,表明丸粒形成得到改善能力。壳聚糖的类型和数量以及添加的海藻酸钠会影响药丸的物理性能,包括大小,圆度,压碎力和药物释放。低分子量壳聚糖生产的颗粒具有更高的平均直径,球形度和压碎力。另外,由低分子量壳聚糖制成并加入海藻酸钠的药丸在0.1 N HCl中显示出较快的药物释放,但在pH 7.4磷酸盐缓冲液中显示出较慢的药物释放。这表明可以通过壳聚糖的分子量来改变从丸粒中释放的药物。总之,壳聚糖的分子量对所得丸粒的形成,物理性质和药物释放具有重大影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号